Product Information
UZEDY ER 125 MG/0.35 ML SYRING is a brand product labeled by Teva Pharmaceuticals USA Inc., priced at $9327.3766 per ML under NDC 51759063010. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on Apr 28, 2023.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
125 mg/.35mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
51759063010
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
RISPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA213586FDA Approved
4/28/2023
On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for UZEDY ER 125 MG/0.35 ML SYRING has been published 118 times since May 22, 2024, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9327.3766 per ML |
|---|---|
| All-time high | $9429.5841 (May 13, 2026) |
| All-time low | $8754.8057 (Nov 20, 2024) |
| 52-week high | $9429.5841 |
| 52-week low | $9066.3639 |
| Median price | $9057.7592 |
| Average price | $9057.3677 |
| Largest weekly change | +4.0% (Jan 7, 2026) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the risperidone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UZEDY ER 125 MG/0.35 ML SYRING?
The current National Average Drug Acquisition Cost (NADAC) for UZEDY ER 125 MG/0.35 ML SYRING, manufactured by Teva Pharmaceuticals USA Inc., is $9327.3766 per ML (NDC 51759063010), effective Aug 19, 2026.
How has the price of UZEDY ER 125 MG/0.35 ML SYRING changed over time?
Over the history we have for it, the NADAC for UZEDY ER 125 MG/0.35 ML SYRING has risen 6.3%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for UZEDY ER 125 MG/0.35 ML SYRING?
Since May 22, 2024, the NADAC for UZEDY ER 125 MG/0.35 ML SYRING has ranged from a low of $8754.8057 (Nov 20, 2024) to a high of $9429.5841 (May 13, 2026), with a median of $9057.7592 per ML.
Are there cheaper alternatives to UZEDY ER 125 MG/0.35 ML SYRING?
No other NADAC-published product currently shares the active ingredient and strength of UZEDY ER 125 MG/0.35 ML SYRING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures UZEDY ER 125 MG/0.35 ML SYRING?
UZEDY ER 125 MG/0.35 ML SYRING (NDC 51759063010) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand product.